HomeAI · summaries
Storia in 3 fonti
Drugmaker Novo Nordisk slashes Wegovy sales forecasts, blaming compounding
Compounding pharmacies are crimping sales of Novo Nordisk's obesity drug Wegovy by making what are essentially copies of the name-brand medicine. The company says it trying to stop them.
Confronto fonti
3 prospettive sulla stessa storiaTimeline cronologica
- ·
cnbc.com
Novo Nordisk shares plunge after Wegovy maker names new CEO, cuts full-year guidance
Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance.
- ·
bbc.com
Wegovy maker Novo Nordisk warns of slower profits as rivals bite
The Danish weight loss drug-maker claims "knock-off" treatments are hitting growth.
